Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) Fails to deliver data
Key failure to deliver metrics for Prestige Consumer Healthcare:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.03 M
- Last 3 months FTD volume: $0.3 M
- Last year FTD volume: $4.31 M
Failures to deliver for Prestige Consumer Healthcare (PBH) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Prestige Consumer Healthcare (PBH) - since 2013
Volume in USD (price x number of shares), data since 2013Prestige Consumer Healthcare (PBH) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.6 M | -83.88% |
| 2023 | $3.73 M | 61.58% |
| 2022 | $2.3 M | -84.98% |
| 2021 | $15.36 M | 165.18% |
| 2020 | $5.79 M | -26.98% |
| 2019 | $7.93 M | -70.86% |
| 2018 | $27.22 M | 307.21% |
| 2017 | $6.68 M | -25.22% |
| 2016 | $8.94 M | -16.96% |
| 2015 | $10.76 M | 206.31% |
| 2014 | $3.51 M | -65.78% |
| 2013 | $10.27 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.13 B | $0.59 B | 🇺🇸 USA |
 Procter & Gamble PG | $52.42 M | $94.91 M | 🇺🇸 USA |
 Novartis NVS | $18.64 M | $83.53 M | 🇨🇭 Switzerland |
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $10.62 M | $0.13 B | 🇺🇸 USA |
 Clorox CLX | $10.12 M | $28.66 M | 🇺🇸 USA |
 CVS Health CVS | $38.96 M | $0.13 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $18.31 M | $24.09 M | 🇬🇧 UK |
 Rite Aid
RAD | $12.18 M | $30.91 M | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $0.14 M | $1.6 M | 🇮🇱 Israel |